Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (21-30 of 308) with videos related to

Pageof 31
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder InterviewsAmr Makady, Anthonius de Boer, Hans Hillege, et al.
Pharmacogenomics|March 15, 2014
Pharmacogenomics of oral antiplatelet drugsAlfi Yasmina, Anthonius de Boer, Olaf H Klungel, et al.
Pharmacy World & Science : PWS|December 16, 2004
Pharmacogenetics in health-care practiceder Zee Anke-Hilse Maitland-van, Olaf H Klungel, Anthonius de Boer
Lancet (London, England)|November 3, 2004
Should rosuvastatin be withdrawn from the market?Stefan R Florentinus, Eibert R Heerdink, Olaf H Klungel, et al.
British Journal of Clinical Pharmacology|August 25, 2020
Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older populationDiana A van Riet-Nales, Katarina Sundberg, Anthonius de Boer, et al.
The New England Journal of Medicine|May 8, 2014
Genotype-guided dosing of vitamin K antagonistsAnke H Maitland-van der Zee, Anthonius de Boer, Vangelis G Manolopoulos, et al.
The Annals of Pharmacotherapy|October 2, 2003
Drug therapy for prevention of recurrent myocardial infarctionMenno E van der Elst, Henk Buurma, Marcel L Bouvy, et al.
The Annals of Pharmacotherapy|January 6, 2005
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic reviewBoris Lg Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
British Journal of Clinical Pharmacology|December 9, 2017
Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications useFariba Ahmadizar, Patrick Souverein, Anthonius de Boer, et al.
British Journal of Clinical Pharmacology|March 3, 2017
Defining the noninferiority margin and analysing noninferiority: An overviewTurki A Althunian, Anthonius de Boer, Rolf H H Groenwold, et al.
Pageof 31

Showing results (21-30 of 308) with videos related to

Sort By:
Pageof 31
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder InterviewsAmr Makady, Anthonius de Boer, Hans Hillege, et al.
Pharmacogenomics|March 15, 2014
Pharmacogenomics of oral antiplatelet drugsAlfi Yasmina, Anthonius de Boer, Olaf H Klungel, et al.
Pharmacy World & Science : PWS|December 16, 2004
Pharmacogenetics in health-care practiceder Zee Anke-Hilse Maitland-van, Olaf H Klungel, Anthonius de Boer
Lancet (London, England)|November 3, 2004
Should rosuvastatin be withdrawn from the market?Stefan R Florentinus, Eibert R Heerdink, Olaf H Klungel, et al.
British Journal of Clinical Pharmacology|August 25, 2020
Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older populationDiana A van Riet-Nales, Katarina Sundberg, Anthonius de Boer, et al.
The New England Journal of Medicine|May 8, 2014
Genotype-guided dosing of vitamin K antagonistsAnke H Maitland-van der Zee, Anthonius de Boer, Vangelis G Manolopoulos, et al.
The Annals of Pharmacotherapy|October 2, 2003
Drug therapy for prevention of recurrent myocardial infarctionMenno E van der Elst, Henk Buurma, Marcel L Bouvy, et al.
The Annals of Pharmacotherapy|January 6, 2005
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic reviewBoris Lg Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
British Journal of Clinical Pharmacology|December 9, 2017
Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications useFariba Ahmadizar, Patrick Souverein, Anthonius de Boer, et al.
British Journal of Clinical Pharmacology|March 3, 2017
Defining the noninferiority margin and analysing noninferiority: An overviewTurki A Althunian, Anthonius de Boer, Rolf H H Groenwold, et al.
Pageof 31